Martin Shkreli Removed As CEO From Another Drug Company03:50
Download

Play
Martin Shkreli (center), then-CEO of Turing Pharmaceuticals, is brought out of 26 Federal Plaza by law enforcement officials after being arrested for securities fraud on December 17 in New York City. (Andrew Burton/Getty Images)
Martin Shkreli (center), then-CEO of Turing Pharmaceuticals, is brought out of 26 Federal Plaza by law enforcement officials after being arrested for securities fraud on December 17 in New York City. (Andrew Burton/Getty Images)
This article is more than 3 years old.

Martin Shkreli is back in the news today, as he has been removed as CEO from his second pharmaceutical company, California biotech firm KaloBios Pharmaceuticals.

Schkreli came under criticism this fall for dramatically hiking the price of a life-saving drug one of his companies, Turing Pharmaceuticals, acquired. The former drug company executive was also arrested last week for securities fraud, related to a hedge fund he ran years ago. Shkreli was removed the day after his arrest as CEO of Turing.

Jason Bellini of the Wall Street Journal joins Here & Now's Jeremy Hobson to discuss the latest news.

Guest

This segment aired on December 22, 2015.

Support the news

+Join the discussion
TwitterfacebookEmail

Support the news